Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada.

ABSTRACT:

Background

There are limited data on outcomes of SARS-CoV-2 infection among infants (<1 year of age). In the absence of approved vaccines for infants, understanding characteristics associated with hospitalization and severe disease from COVID-19 in this age group will help inform clinical management and public health interventions. The objective of this study was to describe the clinical manifestations, disease severity, and characteristics associated with hospitalization among infants infected with the initial strains of SARS-CoV-2.

Methods

This is a national, prospective study of infants with SARS-CoV-2 from April 8th 2020 to May 31st 2021 using the infrastructure of the Canadian Paediatric Surveillance Program. Infants <1 year of age with microbiologically confirmed SARS-

SUBMITTER: Piche-Renaud PP 

PROVIDER: S-EPMC9401116 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature